17 citations
,
October 2020 in “South African Medical Journal” This review highlights that fungal co-infections, notably with Aspergillus and Candida, are common in hospitalized COVID-19 patients, but their impact on disease outcomes remains unclear, indicating a need for further research.
July 2025 in “Journal of Investigative Dermatology” Candida auris uses the immune response to colonize hair follicles.
2 citations
,
January 2004 in “Medical Hypotheses” This hypothesis proposes that fungal infection may be a common risk factor for both male pattern baldness and coronary heart disease, supported by some evidence linking antifungal treatment to improvements in both conditions.
March 2026 in “Frontiers in Bioscience-Elite” This study found that duloxetine and escitalopram exhibited broad-spectrum antimicrobial activity, while buspirone had selective effects, and finasteride disrupted yeast virulence traits, suggesting these drugs could be repurposed as antimicrobial therapies.
April 2024 in “Journal of clinical medicine research” This review discusses seborrheic alopecia in young people, its possible link to fungal infections, and suggests that Malassezia spp. flora may play a key aetiologic role.